Navigation Links
Advanced Life Sciences' Restanza Shows 100% Survival in Tularemia Pivotal Animal Study
Date:12/16/2009

at could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, among others, those relating to technology and product development, market acceptance, government regulation and regulatory approval processes, intellectual property rights and litigation, dependence on collaborative relationships, ability to obtain financing, competitive products, industry trends and other risks identified in Advanced Life Sciences' filings with the Securities and Exchange Commission. Advanced Life Sciences undertakes no obligation to update or alter these forward-looking statements as a result of new information, future events or otherwise.

(1) Journal of the American Medical Association (JAMA) Vol. 285 No. 21, June 6, 2001.

SOURCE Advanced Life Sciences Holdings, Inc.


'/>"/>
SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
4. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
5. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
6. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
7. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
8. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
9. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
10. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
11. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... -- The legalization of medical and recreational marijuana is ... new economic driver – that has taken legislators by ... response to the will of the people about a ... a National Press Club Newsmakers news conference on Thursday, ... the area of marijuana legalization will discuss its far-reaching ...
(Date:7/14/2014)... 2014 Decision Resources Group finds that ... perceptions of emerging drugs for both oncologists and ... (50 medical oncologists and 50 hematological oncologists) and ... care organizations (MCOs), reveals that despite lower familiarity ... of payers say this designation will likely influence ...
(Date:7/14/2014)... HAMILTON, N.J. , July 14, 2014 /PRNewswire/ ... Group, LLC is pleased to announce that its ... the Association for the Assessment and Accreditation of ... humane treatment of animals in science worldwide through ... highest standards for animal care and use in ...
Breaking Medicine Technology:NPC Newsmaker Program: Interpreting smoke signals from the marijuana skirmish line 2Breakthrough Therapy Designation is Likely to Sway Oncologists' Confidence in An Agent and Encourage Prescribing 2Breakthrough Therapy Designation is Likely to Sway Oncologists' Confidence in An Agent and Encourage Prescribing 3Invivotek Awarded Full AAALAC Accreditation for Excellence in Laboratory Animal Care and Use 2
... Accuray Incorporated, (Nasdaq:  ARAY), a global leader in the ... leading academic institutions using CyberKnife radiosurgery in breast cancer ... Southwestern and Fox Chase Cancer Center, will be presented ... for Radiation Oncology (ASTRO) in San Diego from October ...
... 30 Researchers from the University of Bari, Italy, ... creates a sustained viral response (SVR) and protects them ... to determine the long-term clinical outcomes of patients posttransplant ... (HCV) infection of the liver graft. ...
Cached Medicine Technology:CyberKnife Radiosurgery for Early-Stage Breast Cancer 2CyberKnife Radiosurgery for Early-Stage Breast Cancer 3CyberKnife Radiosurgery for Early-Stage Breast Cancer 4CyberKnife Radiosurgery for Early-Stage Breast Cancer 5CyberKnife Radiosurgery for Early-Stage Breast Cancer 6Achieving Sustained Viral Response for Patients with Recurrent Hepatitis C After Transplantation is Key for Long-Term Outcomes 2
(Date:7/14/2014)... Last month Bromell Agency officially launched ... webpage features more detailed information on how clients can ... ATVs, and boats in the state of Louisiana. , ... to the website in order to better educate clients ... purpose of the website, which is to display comprehensive ...
(Date:7/14/2014)... cancer works could lead to the next generation of ... cancer forms when recently evolved genes are damaged, and ... pathways. , Astrobiologists Dr Charley Lineweaver from The ... State University teamed up with oncologist Dr Mark Vincent ... new model. , "The rapid proliferation of cancer ...
(Date:7/14/2014)... (PRWEB) July 14, 2014 The ... & Services [Physical Security, Life Safety, Facility Management], ... Worldwide Forecast & Analysis (2014 - 2019)” defines ... with an in-depth analysis and forecasting of revenues. ... market, various restraints and opportunities impacting it, along ...
(Date:7/14/2014)... This report provides quantitative analysis of ... analysis includes market size data by revenue and ... share data by revenue in 2013 for the ... uses data and information sourced from proprietary databases, ... Scope,     Information on market size ...
(Date:7/14/2014)... July 14, 2014 The Encino ... now offering Lumineers and porcelain veneers. These ... that require more preparation and greater loss of healthy ... shells to conceal visible flaws on the tooth. Encino ... closely with patients to ensure they offer the most ...
Breaking Medicine News(10 mins):Health News:New theory turns cancer on its head 2Health News:Intelligent Building Automation Technologies Market Worth $74.8 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Intelligent Building Automation Technologies Market Worth $74.8 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Intelligent Building Automation Technologies Market Worth $74.8 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Americas Transcatheter Heart Valves Market 2020 Forecasts in New Research Report at LifeScienceIndustryResearch.com 2Health News:Americas Transcatheter Heart Valves Market 2020 Forecasts in New Research Report at LifeScienceIndustryResearch.com 3Health News:Americas Transcatheter Heart Valves Market 2020 Forecasts in New Research Report at LifeScienceIndustryResearch.com 4Health News:Encino Esthetic Dental Group is Now Offering Lumineers and Porcelain Veneers 2
... a distinctive sexual orientation and not an experimental or ... to lesbianism, according to new research published by the ... non-heterosexual women over 10 years found that bisexual women ... sexes. In addition, the research appears to have debunked ...
... Eastern Washington, SPOKANE, Wash., Jan. 15 Washington ... in the Spokane community.,The new facility will initially employ ... WDS in Spokane. Eventually, the number could,expand to 70 ... customer service center in,Colville and we want to expand ...
... Medical Information, Media, and Marketing Benefit All Babies, ... on pregnancy and baby health, expectant moms --,initially overjoyed ... of,Dimes makes it easier than ever for moms to ... reliable information about pregnancy and baby health,in the most ...
... The Pharmaceutical Care,Management Association (PCMA) issued ... analysis released by the Congressional Budget Office ... antitrust exemptions for,independent pharmacies:, "The new ... for,independent pharmacies would increase costs for Medicare ...
... The American Academy of,Ophthalmology expresses its sadness at ... angiogenesis inhibitors sparked major advances in the,treatment of ... or,abnormal angiogenesis, or blood vessel development., "Dr. ... to all of,medicine," said H. Dunbar Hoskins, Jr., ...
... DURHAM, N.C. -- A breast cancer gene,s newly discovered role ... inherit a mutated copy of the gene are at increased ... The discovery also could lead to more effective therapies for ... according to a study led by Duke University Medical Center ...
Cached Medicine News:Health News:Bisexuality not a transitional phase among women, according to new research 2Health News:Washington Dental Service Opens Larger Spokane Office 2Health News:March of Dimes Offers New Resources for Pregnancy and Baby Health 2Health News:March of Dimes Offers New Resources for Pregnancy and Baby Health 3Health News:American Academy of Ophthalmology Mourns Loss of Judah Folkman, MD, Pioneering Researcher 2Health News:New pathway provides more clues about BRCA1 role in breast cancer 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: